Thomas Brunner - Concepedia

Author

Thomas Brunner

University Medical Center Freiburg ORCID

Also Known As

Brunner, T.B., Brunner, Thomas, Brunner, Thomas B, Eble, M J, F. Weidinger, M. Karthaus, T B Brunner, T BRUNNER, T Brunner, T. B. Brunner

426

Publications

10K

Citations

H-Index

107

Concepts

All Affiliations

University Medical Center Freiburg University Hospital Magdeburg Friedrich-Alexander-Universität Erlangen-Nürnberg University of Freiburg Heidelberg University

About

Thomas Brunner is an author at University Medical Center Freiburg specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	43	3K
2	Health Sciences	20	25	1.3K
3	Engineering	4	4	534
4	Natural Sciences	1	1	147
5	Biochemistry	1	1	147

Thomas Brunner

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12 Emmanouil Fokas, Michael Allgäuer, Bülent Polat, Journal of Clinical Oncology	2019	505
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation Emmanouil Fokas, Remko Prevo, John R. Pollard, Cell Death and Disease	2012	353
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286) Jens Hoeppner, Florian Lordick, Thomas Brunner, BMC Cancer	2016	343
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer Henriette Golcher, Thomas Brunner, Helmut Witzigmann, Strahlentherapie und Onkologie	2014	327
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Emmanouil Fokas, Anke Schlenska‐Lange, Bülent Polat, JAMA Oncology	2021	324
The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy Remko Prevo, Emmanouil Fokas, Philip M. Reaper, Cancer Biology & Therapy ImmunologyPancreatic Cancer CellsCancer BiologyTumor BiologyRadiation Medicine	2012	242
Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through β1-Integrin Signaling Tine S. Mantoni, Serena Lunardi, Osama Al‐Assar, Cancer Research PathologyCancer BiologyTumor BiologyPancreatic CancerCell Regulation	2011	213
Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy Thomas Grabinger, Lisanne Luks, Feodora Ivanova Kostadinova, Cell Death and Disease Iec DeathImmunotoxicologyImmunologyGastroenterologyPathology	2014	208
Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography Kenneth A. Miles, Ting‐Yim Lee, Vicky Goh, European Radiology Computed TomographyNeuro-oncologyCurrent StatusEngineeringOncologic Imaging	2012	189
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp, The Lancet Oncology EngineeringOncologic ImagingMedical ImagingBiomedical ImagingMolecular Imaging	2020	169

Page 1